{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:16:34Z","timestamp":1740107794680,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10147-016-1061-2","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T15:16:11Z","timestamp":1478790971000},"page":"269-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population"],"prefix":"10.1007","volume":"22","author":[{"given":"Yoshitaka","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Narahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Tamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Taneishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Nakatsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Uneno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruko","family":"Tomono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,10]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2014","unstructured":"Ferlay J, Soerjomataram II, Dikshit R et al (2014) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386. doi:\n                    10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0169-5002(00)00181-1","volume":"31","author":"SA Khuder","year":"2001","unstructured":"Khuder SA (2001) Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 31:139\u2013148","journal-title":"Lung Cancer"},{"key":"1061_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ijc.23033","volume":"122","author":"S Gandini","year":"2008","unstructured":"Gandini S, Botteri E, Iodice S et al (2008) Tobacco smoking and cancer: a meta-analysis. Int J Cancer 122:155\u2013164. doi:\n                    10.1002\/ijc.23033","journal-title":"Int J Cancer"},{"key":"1061_CR4","doi-asserted-by":"publisher","unstructured":"Espina C, Straif K, Friis S, et al (2015) European Code against Cancer 4th edition: Environment, occupation and cancer. Cancer Epidemiol 20\u201333. doi:\n                    10.1016\/j.canep.2015.03.017","DOI":"10.1016\/j.canep.2015.03.017"},{"key":"1061_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/carcin\/19.5.813","volume":"19","author":"E Taioli","year":"1998","unstructured":"Taioli E, Ford J, Trachman J et al (1998) Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 19:813\u2013817. doi:\n                    10.1093\/carcin\/19.5.813","journal-title":"Carcinogenesis"},{"key":"1061_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0014-5793(90)80721-T","volume":"263","author":"K Kawajiri","year":"1990","unstructured":"Kawajiri K, Nakachi K, Imai K et al (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263:131\u2013133. doi:\n                    10.1016\/0014-5793(90)80721-T","journal-title":"FEBS Lett"},{"key":"1061_CR7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3892\/ol.2012.665","volume":"3","author":"K Pliarchopoulou","year":"2012","unstructured":"Pliarchopoulou K, Voutsinas G, Papaxoinis G et al (2012) Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers. Oncol Lett 3:1301\u20131306. doi:\n                    10.3892\/ol.2012.665","journal-title":"Oncol Lett"},{"key":"1061_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1158\/1055-9965.EPI-03-0070","volume":"13","author":"JL Fang","year":"2004","unstructured":"Fang JL, Lazarus P (2004) Correlation between the UDP-glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(\u2212) in liver microsomes from subjects with. Cancer Epidemiol Biomark Prev 13:102\u2013109. doi:\n                    10.1158\/1055-9965.EPI-03-0070","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1061_CR9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/jnci\/91.14.1194","volume":"91","author":"SS Hecht","year":"2000","unstructured":"Hecht SS (2000) Tobacco smoke carcinogen and lung cancer. J Natl Cancer Inst 91:1194\u20131210","journal-title":"J Natl Cancer Inst"},{"key":"1061_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10147-008-0821-z","volume":"14","author":"M Onoue","year":"2009","unstructured":"Onoue M, Terada T, Kobayashi M et al (2009) UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients. Int J Clin Oncol 14:136\u2013142. doi:\n                    10.1007\/s10147-008-0821-z","journal-title":"Int J Clin Oncol"},{"key":"1061_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2307\/2283989","volume":"62","author":"Z Sidak","year":"1967","unstructured":"Sidak Z (1967) Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc 62:626. doi:\n                    10.2307\/2283989","journal-title":"J Am Stat Assoc"},{"key":"1061_CR12","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1542\/peds.106.5.e59","volume":"106","author":"Y Maruo","year":"2000","unstructured":"Maruo Y, Nishizawa K, Sato H et al (2000) Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics 106:E59. doi:\n                    10.1542\/peds.106.5.e59","journal-title":"Pediatrics"},{"key":"1061_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1442-200x.2005.02030.x","volume":"47","author":"M Kanai","year":"2005","unstructured":"Kanai M, Kijima K, Shirahata E et al (2005) Neonatal hyperbilirubinemia and the bilirubin uridine diphosphate-glucuronosyltransferase gene: the common -3263T>\u00a0G mutation of phenobarbital response enhancer module is not associated with the neonatal hyperbilirubinemia in Japanese. Pediatr Int 47:137\u2013141. doi:\n                    10.1111\/j.1442-200x.2005.02030.x","journal-title":"Pediatr Int"},{"key":"1061_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4251\/wjgo.v4.i7.170","volume":"4","author":"M Kobayashi","year":"2012","unstructured":"Kobayashi M (2012) Is there diversity among UGT1A1 polymorphism in Japan. World J Gastrointest Oncol 4:170. doi:\n                    10.4251\/wjgo.v4.i7.170","journal-title":"World J Gastrointest Oncol"},{"key":"1061_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","volume":"333","author":"PJ Bosma","year":"1995","unstructured":"Bosma PJ, Chowdhury JR, Bakker C et al (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert\u2019s syndrome. N Engl J Med 333:1171\u20131175. doi:\n                    10.1056\/NEJM199511023331802","journal-title":"N Engl J Med"},{"key":"1061_CR16","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","volume":"95","author":"E Beutler","year":"1998","unstructured":"Beutler E, Gelbart T, Demina A (1998) Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 95:8170\u20138174","journal-title":"Proc Natl Acad Sci USA"},{"key":"1061_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1124\/mol.62.3.446","volume":"62","author":"RH Tukey","year":"2002","unstructured":"Tukey RH (2002) Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity. Mol Pharmacol 62:446\u2013450. doi:\n                    10.1124\/mol.62.3.446","journal-title":"Mol Pharmacol"},{"key":"1061_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0925-4439(98)00013-1","volume":"1406","author":"K Yamamoto","year":"1998","unstructured":"Yamamoto K, Sato H, Fujiyama Y et al (1998) Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert\u2019s syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta Mol Basis Dis 1406:267\u2013273. doi:\n                    10.1016\/S0925-4439(98)00013-1","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1061_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature06846","volume":"452","author":"TE Thorgeirsson","year":"2008","unstructured":"Thorgeirsson TE, Geller F, Sulem P et al (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:638\u2013642. doi:\n                    10.1038\/nature06846","journal-title":"Nature"},{"issue":"Suppl 5","key":"1061_CR20","doi-asserted-by":"publisher","first-page":"S454","DOI":"10.3978\/j.issn.2072-1439.2013.08.06","volume":"5","author":"IA Yang","year":"2013","unstructured":"Yang IA, Holloway JW, Fong KM (2013) Genetic susceptibility to lung cancer and co-morbidities. J Thorac Dis 5(Suppl 5):S454\u2013S462. doi:\n                    10.3978\/j.issn.2072-1439.2013.08.06","journal-title":"J Thorac Dis"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-016-1061-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T09:33:49Z","timestamp":1589448829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-016-1061-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,10]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s10147-016-1061-2","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2016,11,10]]},"assertion":[{"value":"31 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Narahara received research funding from Toyobo Biotechnology Foundation. Dr. Muto received research funding from Taiho Pharmaceutical and Mitsui Knowledge Industry. No other potential conflict of interest relevant to this article was reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}